Literature DB >> 2905705

Gas chromatographic method for the determination of cetirizine in plasma.

E Baltes1, R Coupez, L Brouwers, J Gobert.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905705     DOI: 10.1016/s0378-4347(00)83145-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  7 in total

1.  The effect of 2 weeks treatment with cetirizine on bronchial reactivity to methacholine in asthma.

Authors:  J P Finnerty; S T Holgate; J P Rihoux
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

Review 2.  Pharmacokinetic optimisation of histamine H1-receptor antagonist therapy.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1991-11       Impact factor: 6.447

Review 3.  Cetirizine. An updated review of its pharmacological properties and therapeutic efficacy.

Authors:  J P Rihoux; S Mariz
Journal:  Clin Rev Allergy       Date:  1993

Review 4.  Clinical pharmacology of new histamine H1 receptor antagonists.

Authors:  F E Simons; K J Simons
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 5.  Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria.

Authors:  D M Campoli-Richards; M M Buckley; A Fitton
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

6.  Pharmacokinetics of cetirizine in tear fluid after a single oral dose.

Authors:  Lucia Grumetto; Gilda Cennamo; Antonio Del Prete; Maria I La Rotonda; Francesco Barbato
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

7.  Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years.

Authors:  Maria Pitsiu; Ziad Hussein; Oneeb Majid; Leon Aarons; Marc de Longueville; Armel Stockis
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.